Trial NCT00300885

View at ClinicalTrials.gov 
Org. Study IDs: 11961
Secondary IDs: 2005-005245-19

Last trial update was posted on 2014-11-04

MeSH Interventions

Albumin-Bound Paclitaxel Carboplatin Paclitaxel Sorafenib

MeSH Conditions

Carcinoma, Non-Small-Cell Lung Lung Neoplasms

Other Conditions

Carcinoma, Non-Small Cell Lung

Stopping Reasons

Based on the results of the interim analysis, it was determined that the study would not meet its primary efficacy endpoint and the study was terminated early.

Limitations And Caveats

Based on the results of the interim analysis, it was determined that the study would not meet its primary efficacy endpoint and the study was terminated early. The planned biomarker analysis was suspended due to early termination.

Result Publications


Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID